Bath & Body Works Names New CEO and Board Chair
Ticker: BBWI · Form: 8-K · Filed: Apr 22, 2024 · CIK: 701985
| Field | Detail |
|---|---|
| Company | Bath & Body Works, INC. (BBWI) |
| Form Type | 8-K |
| Filed Date | Apr 22, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment, board-of-directors
Related Tickers: BBY
TL;DR
Sarah Nash is now permanent CEO & Chair of Bath & Body Works, Wendy Arlin is Lead Independent Director.
AI Summary
Bath & Body Works, Inc. announced on April 22, 2024, that Sarah Nash will transition from Interim CEO to CEO, effective April 20, 2024. Concurrently, she will also serve as Chair of the Board of Directors. The company also announced the appointment of Wendy Arlin as Lead Independent Director.
Why It Matters
This leadership change signifies a permanent CEO appointment and a shift in board structure, which could impact the company's strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, potentially impacting investor confidence.
Key Players & Entities
- Bath & Body Works, Inc. (company) — Registrant
- Sarah Nash (person) — Interim CEO transitioning to CEO and Chair of the Board
- Wendy Arlin (person) — Appointed Lead Independent Director
- April 20, 2024 (date) — Effective date of CEO transition
- April 22, 2024 (date) — Date of report
FAQ
What is the effective date of Sarah Nash's appointment as CEO?
Sarah Nash's appointment as CEO is effective April 20, 2024.
What other role will Sarah Nash assume?
Sarah Nash will also serve as Chair of the Board of Directors.
Who has been appointed as the Lead Independent Director?
Wendy Arlin has been appointed as the Lead Independent Director.
What was Sarah Nash's previous role?
Sarah Nash was previously the Interim CEO.
What is the filing date of this 8-K report?
This 8-K report was filed on April 22, 2024.
Filing Stats: 475 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-04-22 06:08:20
Key Financial Figures
- $0.50 — nge on which registered Common Stock, $0.50 Par Value BBWI The New York Stock Exc
Filing Documents
- dp210091_8k.htm (8-K) — 22KB
- 0000950103-24-005537.txt ( ) — 189KB
- bbwi-20240420.xsd (EX-101.SCH) — 3KB
- bbwi-20240420_lab.xml (EX-101.LAB) — 33KB
- bbwi-20240420_pre.xml (EX-101.PRE) — 22KB
- dp210091_8k_htm.xml (XML) — 3KB
02. Departure of Directors or Certain Officers; Election
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 20, 2024, Thomas J. Kuhn notified the Board of Directors (the "Board") of Bath & Body Works, Inc. (the "Company") of his resignation of service as a director of the Company, effective the same date. Effective as of Mr. Kuhn's resignation, the size of the Board has been reduced to 12 directors. The size of the Board will subsequently be reduced to 10 directors effective upon completion of the Company's 2024 Annual Meeting of Stockholders following the previously disclosed decisions of Patricia S. Bellinger and Michael G. Morris not to stand for re-election.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BATH & BODY WORKS, INC. By: /s/ Michael C. Wu Name: Michael C. Wu Title: Chief Legal Officer and Corporate Secretary Date: April 22, 2024